Wiskott-Aldrich syndrome complicated by an atypical lymphoproliferative disorder: A case report

Journal of Microbiology, Immunology and Infection

Volumn 38, Issue 4, 2005, Pages 289-292

  Ma, Yi Chun ^a   Shyur, Shyh Dar ^a   Ho, Tzu Yuan ^a   Huang, Li Hsin ^a   Wu, Jiunn Yi ^a   Liang, Der Cherng ^a   Chien, Yin Hsiu ^b  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Differential diagnosis; Lymphoproliferative disorders; Thrombocytopenia; Wiskott Aldrich syndrome

Indexed keywords

COTRIMOXAZOLE; PENICILLIN G;

ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; HUMAN; HUMAN TISSUE; LABORATORY TEST; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOPROLIFERATIVE DISEASE; MALE; SPLENECTOMY; THROMBOCYTOPENIA; WISKOTT ALDRICH SYNDROME;

CHILD, PRESCHOOL; HUMANS; LYMPH NODES; LYMPHOPROLIFERATIVE DISORDERS; MALE; WISKOTT-ALDRICH SYNDROME;

EID: 24744466118     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Ochs HD, Nelson DL, Stiehm ER. Other well-defined immuno-deficiency syndrome. In: Stieham ER, Ochs HD, Winkelstein JA, eds. Immunologic disorders in infants and children. 5th ed. Philadelphia: Elsevier Inc.; 2004:506-16.
2. Filipovich AH, Mertens A, Robison L, Ambinder R, Shapiro RS, Frizzera G. Lymphoproliferative disorders associated with primary immunodeficiencies. In: Magrath IT, ed. The non-Hodgkin's lymphomas. 2nd ed. London: Arnold; 1997:459-69.
3. Elenitoba-Johnson KS, Jaffe ES. Lymphoproliferative disorders associated with congenital immunodeficiencies. Semin Diagn Pathol 1997;14:35-47.
4. Frizzera G. Atypical lymphoproliferative disorders. In: Knowles DM, ed. Neoplastic hematopathology. Maryland: Williams and Wilkins Company; 1992:459-86.
5. Nugent DJ, Kunicki TJ. Immune-mediated hematologic and oncologic disorders. In: Stieham ER, Ochs HD, Winkelstein JA, eds. Immunologic disorders in infants and children. 5th ed. Philadelphia: Elsevier Inc.; 2004:1253-81.
6. Knowles DM. Immunodeficiency-associated lymphoproliferative disorders. Mod Pathol 1999;12:200-17.
7. Spector BD, Perry GS, Kersey JH. Genetically determined immunodeficiency diseases (GDID) and malignancy: report from the immunodeficiency-cancer registry. Clin Immunol Immunopathol 1978;11:12-29.
8. Mueller BU. Lymphoproliferative disorders and malignancies related to immunodeficiencies. In: Pizzo PA, Poplack DG, eds. Principles and practice of pediatric oncology. 4th ed. Philadelphia: Williams and Wilkins Company; 2002:707-31.
9. Ioachim HL. Atypical lymphoid hyperplasia. In: Ioachim HL, ed. Lymph node pathology. 2nd ed. Philadelphia: Lippincott Company; 1994:178-85.
10. Beltrami CA. The atypical lymphoproliferative disorders: tissue expression. Clin Exp Rheumatol 1996;14(Suppl 14):S15-9.
11. Buckley RH. Primary immunodeficiency diseases. In: Goldman L, Bennett JC, eds. Cecil textbook of medicine. 21st ed. Philadelphia: WB Saunders; 2000:1423-7.
12. Greiner TC, Gross TG. Atypical immune lymphoproliferations. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, et al, eds. Hematology: basic principles and practices. 3rd ed. Philadelphia: Churchill Livingstone, Inc.; 2000:1432-9.
13. Kersey JH, Shapiro RS, Filipovich AH. Relationship of immunodeficiency to lymphoid malignancy. Pediatr Infect Dis J 1988;7(Suppl):S10-2.
14. Ozsahin H, Le Deist F, Benkerrou M, Cavazzana-Calvo M, Gomez L, Griscelli C, et al. Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center. J Pediatr 1996;129:238-44.